Premium Nahrungsergänzungsmittel | artgerecht

FTA-ABS Test – Syphilis Confirmatory Test Explained

The FTA-ABS test is a highly specific blood test used to confirm a syphilis infection by detecting antibodies against the bacterium Treponema pallidum.

Regular tips about health Regular tips about health

Things worth knowing about "FTA-ABS Test"

The FTA-ABS test is a highly specific blood test used to confirm a syphilis infection by detecting antibodies against the bacterium Treponema pallidum.

What is the FTA-ABS Test?

The FTA-ABS test (Fluorescent Treponemal Antibody Absorption test) is a serological diagnostic method used to confirm a diagnosis of syphilis. It detects antibodies directed specifically against Treponema pallidum, the bacterium responsible for syphilis. Introduced in the 1960s, it remains one of the most reliable confirmatory tests in syphilis diagnostics today.

How Does the FTA-ABS Test Work?

A blood sample is taken from the patient, and the serum (the liquid component of blood) is first treated with an absorption agent to remove non-specific antibodies that could cause false reactions. The pre-treated serum is then applied to a glass slide coated with inactivated Treponema pallidum bacteria.

If the patient has developed antibodies against the syphilis pathogen, these antibodies will bind to the bacteria on the slide. A secondary antibody labeled with a fluorescent dye is then added. Under a fluorescence microscope, the bacteria will glow brightly if antibodies are present, indicating a positive test result.

When is the FTA-ABS Test Used?

The FTA-ABS test is typically performed when a syphilis screening test (such as the TPHA or VDRL test) has returned a positive or inconclusive result. It serves as a confirmatory test due to its high specificity for Treponema pallidum. Common indications include:

Confirmation of syphilis after a positive screening test
Clarification of inconclusive serological results
Prenatal syphilis screening during pregnancy
Testing of individuals at increased risk of infection
Evaluation of neurological symptoms potentially indicating neurosyphilis

Interpreting the Test Results

Positive Result

A positive FTA-ABS test indicates that the body has produced antibodies against Treponema pallidum. This can reflect an active or past syphilis infection. An important consideration: the test typically remains positive for life, even after successful treatment. It is therefore not suitable for monitoring treatment response.

Negative Result

A negative result makes a syphilis infection very unlikely. However, in very early stages of infection, sufficient antibodies may not yet have developed. If clinical suspicion remains high, repeat testing is recommended.

False-Positive Results

Although the FTA-ABS test is highly specific, false-positive results can occasionally occur, for example in autoimmune conditions such as systemic lupus erythematosus (SLE) or in infections caused by related treponemal organisms (e.g., yaws, pinta).

Advantages and Limitations

The FTA-ABS test is characterized by very high sensitivity and specificity. It can yield positive results even in the early stages of syphilis, when other tests may still be negative. Its limitations include technical complexity and the inability to distinguish between an active and a previously treated infection.

Comparison with Other Syphilis Tests

Several different tests are used in combination for syphilis diagnostics:

TPHA / TPPA test: Also specific for Treponema pallidum; commonly used as a screening test
VDRL / RPR test: Non-treponemal test; useful for monitoring disease activity and treatment response
FTA-ABS test: Highly specific confirmatory test; particularly sensitive in early-stage infection

References

Workowski KA, Bachmann LH et al.: Sexually Transmitted Infections Treatment Guidelines. MMWR Recomm Rep. 2021;70(4):1–187.
World Health Organization (WHO): Guidelines for the Treatment of Treponema pallidum (Syphilis). Geneva, 2016. Available at: https://www.who.int
Larsen SA, Steiner BM, Rudolph AH: Laboratory Diagnosis and Interpretation of Tests for Syphilis. Clinical Microbiology Reviews. 1995;8(1):1–21.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.